Advertisement

Methylphenidate Hydrochloride Chewable Tablets

[18 November 2016]

Products Affected - Description

Methylin chewable tablets, Shionogi Pharma
2.5 mg tablets, 100 count (NDC 59630-0760-10)
5 mg tablets, 100 count (NDC 59630-0761-10)
10 mg tablets, 100 count(NDC 59630-0762-10)

Reason for the Shortage

  • Shionogi Pharma has Methylin chewable tablets on shortage due to manufacturing issues.
  • Gavis launched methylphenidate chewable tablets in April 2015.

Available Products

Methylphenidate chewable tablets, Gavis Pharmaceuticals
2.5 mg, 100 count (NDC 43386-0570-01)
5 mg tablets, 100 count (NDC 43386-0571-01)
10 mg tablets, 100 count (NDC 43386-0572-01)

Estimated Resupply Dates

Shionogi Pharma has all Methylin chewable tablets on long-term back order and the company cannot estimate a release date.

Related Shortages

Updated

November 18, September 6, July 22, June 16, April 11, March 7, February 24, 2016; December 16, September 23, July 9, April 8 and 3, January 23 and 9, 2015; December 18, 10 and 3, November 5, October 10, September 24 and 10, August 15, June 23 and 5, April 15, March 27, February 11, January 17, 2014; November 14, October 17, September 23, 16 and 12, August 28 and 13, July 29, 11 and 3, June 20 and 7, May 22 and 15, April 5, March 8 and 5, February 22, January 24, 2013; November 30 and 2, October 1, September 12, July 18, June 25, May 17, April 23, March 8, February 17, January 30 and 13, 2012; December 14, October 19 and 6, September 21, August 3, July 6, June 23 and 6, May 19, 13 and 5, April 8, March 23 and 8, 2011, University of Utah, Drug Information Service. Copyright 2016, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
Advertisement
ASHP Product Listing